Short Interest in XOMA Co. (NASDAQ:XOMAO) Decreases By 52.8%

XOMA Co. (NASDAQ:XOMAO) was the recipient of a significant decrease in short interest in May. As of May 15th, there was short interest totaling 137 shares, a decrease of 52.8% from the April 30th total of 290 shares. Based on an average daily trading volume, of 7,344 shares, the short-interest ratio is currently 0.0 days.

XOMA Stock Up 0.1%

XOMA stock traded up $0.02 during midday trading on Tuesday, reaching $25.36. 2,415 shares of the company traded hands, compared to its average volume of 4,001. The business has a 50 day moving average of $25.45 and a two-hundred day moving average of $25.42. XOMA has a 12 month low of $24.86 and a 12 month high of $26.40.

About XOMA

XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.

In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.